Wandong Zhang

Dr. Wandong Zhang is an Associate Director at BioMarin in the Quality Analytical Technologies. Since 2019, she has led team focusing on method validation and optimization for clinical phase AAV based gene therapy programs. Prior to BioMarin, Wandong was a scientist in the Analytical Development at Bayer and a Sr. Scientist in drug discovery at Lexicon Pharmaceuticals. Wandong earned her PhD in Biochemistry and Molecular Biology from Rutgers University.